Association between pre‐operative sodium‐glucose cotransporter‐2 inhibitor use and postoperative outcomes: a propensity score‐matched analysis of the <scp>TriNetX</scp> database
Our study showed a significantly reduced risk of postoperative mortality and morbidity associated with pre-operative sodium-glucose cotransporter-2 inhibitor use in patients with type 2 diabetes mellitus, including a notably lower rate of diabetic ketoacidosis, contrary to previous concerns. Randomised controlled trials are warranted to validate these findings.
Authors
- Ying‐Hsuan Tai (ORCID: https://orcid.org/0000-0002-5210-6873)
- Jui‐Tai Chen (ORCID: https://orcid.org/0000-0002-4018-7303)
- Juan Pablo Cata (ORCID: https://orcid.org/0000-0002-3156-1682)
- Yih‐Giun Cherng (ORCID: https://orcid.org/0000-0002-0201-4380)
- Chi‐Feng Hsieh
- Hsiang‐Ling Wu
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
- Taipei City Hospital (TW)
- Taipei Medical University-Shuang Ho Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Anaesthesia
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1111/anae.70024
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29